A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults

Published 2015 View Full Article

Authors

Keywords

Staphylococcus aureus, Vaccine, Functional antibodies, Capsule proteins, Clinicaltrials.gov Identifier. NCT01018641

Journal

VACCINE

Volume 33, Issue 15, Pages 1846-1854

Publisher

Elsevier BV

Online

2015-02-21

DOI

10.1016/j.vaccine.2015.02.024

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started